Tartar emetic (potassium antimony tartrate) has been used since a long time as the drug of choice for the treatment of Bilharziasis in Egypt. This drug, though effective, has severe side effects. A newly synthesized trivalent antimony preparation (piperazine di-antimonyl tratrate) Bilharcid, has proved in animal experiments to be less toxic, more effective, and having little side effects. The drug was tried in various schemes on various age groups of patients infected with S. haematobium. Control cases were treated with tartar emetic. Urine analysis was done for the detection of living or dead ova before and after treatment. E.C.G., alkaline phosphatase, serum transaminase, lactic dehydrogenase, and urea tests were done before and after treatment. Follow up studies were recorded for three months after treatment. Results are presented in the full text.
Download full-text PDF |
Source |
---|
Environ Int
January 2025
National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, China. Electronic address:
The increasing antimony (Sb) contamination prevalence poses a concern owing to its toxicity and potential carcinogenic properties. However, mechanisms underlying the microbial conversion of soluble Sb into insoluble Sb minerals remain unclear. In the present study, Enterobacter sp.
View Article and Find Full Text PDFSci Total Environ
December 2024
Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha 410078, PR China. Electronic address:
Ecotoxicol Environ Saf
October 2024
Institute of Reproductive Medicine, Medical School, Nantong University, Nantong 226019, China. Electronic address:
Clin Toxicol (Phila)
December 2023
IA Poison Control Center, Iowa City, IA, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!